Loading stock data…
ALGN
$161.75-4.04 (-2.44%)
Pre-Market$163.34+1.59 (+0.98%)· Last close May 13
Align Technology, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Align Technology, Inc. in the Healthcare sector is trading at $161.75. Wall Street consensus targets $209.07 (14 analysts), implying a +29.3% move over the next 12 months. The stock is currently 22% below its 52-week high of $208.31, remaining 2.8% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 21 is oversold, raising the odds of a near-term bounce. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +29.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 21) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Sector + growth-aware fair-multiple estimate. Fair P/E = sector-anchor + (ROE × 25) + (max(revenue growth, earnings growth) × 30), capped at 1.6× sector. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. The sector anchor (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) keeps quality compounders from being mechanically penalized against utility multiples. Result is a normalised multiple gauge — not a price target.
Current Price$161.75
Potential Downside
37.6%
Whystock Fair Value$100.98
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus14 analysts
Buy
Mean target$209.07+29.3%
Range$175.00 – $240.00
Fundamentals
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$14.04B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
34.76
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.81
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.81%
Volume
Today's trading volume
618,188
Recent News
Shareholder Pressure Meets New Digital Workflows For Align Technology
Align Technology (NasdaqGS:ALGN) is facing increased shareholder activism that could influence its strategy, governance, and capital allocation. The activism is emerging at the same time as Align rolls out new digital orthodontic workflows, including the Invisalign Specifix Attachment System and upgraded planning tools. This combination of external pressure and product launches is drawing attention to how management will prioritize resources and decision making. For investors tracking Align...
ALGN vs. WST: Which Stock Is the Better Value Option?
ALGN vs. WST: Which Stock Is the Better Value Option?
What Makes Align Technology (ALGN) a New Buy Stock
Align Technology (ALGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?
Here is how Agenus (AGEN) and Align Technology (ALGN) have performed compared to their sector so far this year.
Earnings Beat: Align Technology, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Last week, you might have seen that Align Technology, Inc. ( NASDAQ:ALGN ) released its first-quarter result to the...